Calculus Capital Ltd. — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Resurrect Bioresurrect.bioinFeb 2026 · $8.1M
Resurrect Bio develops genetic disease-resistance traits for crops by restoring plant R-genes, using its FloraFold AI platform and rapid in-planta screening for trait discovery.
AgTechAI & Machine LearningBiotech
Cian Duggan(CEO / Co-Founder)Tolga Bozkurt(Co-Founder)Sophien Kamoun(Co-Founder)
Co-investorsFuture Planet CapitalSynBioVenUK Innovation & Science Seed FundAgFunderPymwymic
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.